Stocks
Themes
Market Cap Ranking
Trading Strategies
SEC Filings TLDR
Analysis Reports
Sign in
Loading stock data...
Loading updates and signals...
Back
ESLA
$2.46
-0.40%
Analyze
1M
+105.0%
3M
+170.3%
1Y
+173.3%
Market Cap:
$91.18M
Estrella Immunopharma Inc.
Healthcare |
Biotechnology
Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company is headquartered in EmeryVille, California.
Click "Analyze" to generate stock analysis
ESLA Price Trend and Signals
ESLA Financials
Signals
News
SEC Filings
Holders
Research Reports
AI Analysis
2025-10-28
Somewhat Bullish
price_signal
Yearly high detected.
2025-10-24
Somewhat Bullish
price_signal
Yearly high detected.
2025-10-23
Somewhat Bullish
price_signal
Yearly high detected.
2025-10-22
Somewhat Bullish
price_signal
Yearly high detected.
2025-10-22
Bullish
price_signal
Large price change detected: 24.6%.
2025-10-20
Somewhat Bullish
price_signal
Yearly high detected.
2025-10-17
Somewhat Bullish
price_signal
Yearly high detected.
2025-10-15
Somewhat Bullish
price_signal
Yearly high detected.
2025-10-14
Somewhat Bullish
price_signal
Yearly high detected.
2025-10-13
Somewhat Bullish
macd_signal
Golden cross above zero detected.
2025-10-13
Somewhat Bullish
price_signal
Yearly high detected.
2025-10-13
Bullish
price_signal
Large price change detected: 16.28%.
2025-10-09
Somewhat Bearish
macd_signal
Dead cross above zero detected.